Introduction
============

Fungi are the most common microorganisms and have clinical importance. Few of them are pathogenic or opportunistic pathogen and results in morbidity and mortality to human beings. There is a rise in opportunistic fungal infections in recent years due to increased incidence of immunocompromised host ([@B15]; [@B43]). After *Candida albicans*, the leading causes of fungal infections in immunocompromised individuals are from *Aspergillus* species. *Aspergillus* is one of the most ubiquitous medically important opportunistic fungi ([@B52]). The genus *Aspergillus*, contains about 40 species that can cause infection ([@B50]), among them *A. fumigatus*, *A. flavus*, and *A. terreus* are the leading cause of invasive Aspergillosis in immunocompromised individuals. These species produce conidia at a concentration of around 1--100 conidia per m^3^ ([@B6]). Human routinely inhale hundreds of these conidia per day, despite these exposure to *Aspergillus* conidia, human do not develop any disease due to the clearance of conidia from lung by innate immunity especially phagocytic cells ([@B15]; [@B43]). However, due to rise in immunocompromised host, e.g., patients receiving organ transplant, immunosuppressive therapy for autoimmune or neoplastic disease and HIV patients, inhaled conidia if not cleared in these host, colonization of *Aspergillus* occurs ([@B49]). The adaptive immune response in human responsible for conidia clearance is not well understood in immunocompetent host as well as where conidia colonize in immunocompromised host. It is worth to note that secondary metabolites (e.g., Gliotoxins, Aflatoxins) excreted by *Aspergillus* especially have been recognized to modulate immunological responses ([@B45]). Thus, we reviewed recent advances made in immune responses against *Aspergillus* species in mice model studies and clinical aspergillosis patients. *A. fumigatus* is the prominent species, which cause 90% of Aspergillosis followed by *A. flavus* and *A. terreus*. Studies have showed that *Aspergillus* species associated with infection after hematopoietic stem cell transplantation include *A. fumigatus* with 56% followed by *A. flavus* (18.7%) and *A. terreus* (16%) ([@B48]; [@B33]). The involvement of *Aspergillus* infection in pulmonary tuberculosis and in asthmatic patients has been reported by Denning et al. It has been estimated annually at least 372,385 patients developed chronic pulmonary aspergillosis worldwide following treated pulmonary tuberculosis ([@B20]). Similarly, around 4,837,000 patients develop Allergic bronchopulmonary aspergillosis out of 193 million adults with active asthma ([@B21]). However, in a recent study of Indian population by [@B1] the estimated ABPA burden was 1.38 million out of 27.6 million adults with asthma. This review touches different aspect of antifungal immunity against aspergillosis that include antigen presenting cells (APCs), dendritic cells (DCs), fungal pattern recognition receptors (PRRs), T~H~-cells with their subsets profile during infection associated to *Aspergillus* species at different site of infection, e.g., lung, kidney, and brain.

Recognition of *Aspergillus* by the Host
========================================

Presentation of Pathogen via Soluble Receptors and Cell Bound Receptors
-----------------------------------------------------------------------

After the inhalation of *A. fumigatus* conidia, they are entrapped by the lung alveoli and if they are not efficiently cleared from lung, they germinate and establish lung infection termed invasive pulmonary aspergillosis and it may also disseminates to other organs if not treated ([@B39]). The recognition of *A. fumigatus* conidia and hyphae occurs by PRRs those include soluble receptors and cell-bound receptors. Conidial germination starts with hydrophobic layer degradation and exposure of inner cell wall components mainly polysaccharides, which includes chitin, β-glucan, mannan, and galactomannan. These are termed as pathogen associated molecular patterns (PAMP), are recognized by PRRs ([@B36]; [@B26]). PRRs soluble receptor such as pulmonary collectins, family of C-type lectins, pentraxin-3, pulmonary surfactant proteins-A and D have been reported in aspergillosis. Further, the cell-bound receptors in association with aspergillosis include Toll like receptor-2 (TLR), TLR-4 and TLR-9, which potentially induce the production of pro-inflammatory cytokines and reactive oxygen species through MyD88 signaling pathway ([@B54]).

Antigen Presenting Cells and T-cell Differentiation
===================================================

Antigen Presenting Cells Triggers Cytokines Production
------------------------------------------------------

The activation of the innate immunity through PRRs present on the APCs that regulate the development of T-cell. APCs express wide-array of PRRs that provides the link between adaptive and innate immunity ([@B39]). APCs, dominantly DCs, are responsible for antigen monitoring and then shaping T-cell response by secreting cytokines and chemokines. DCs express PRRs on their cell surface and endosomal compartments, which serve to recognize PAMPs. After interaction with DCs, naive T-cells are activated. The activation of T-cell response is regulated by the cytokines milieu predominantly framed by DCs ([@B2]). Chemokines secreted by DCs recruit the phagocytic cells to infected areas to clear the *Aspergillus* components. APC cells, e.g., monocytes differentiate into distinct sub-populations of CD14^+^ and CD16^+^ cells after *A*. *fumigatus* conidia infection ([@B44]). Monocytes interact with *Aspergillus* antigens resulting in maturation of monocytes into macrophages or DCs. Macrophages and DCs interact with antigens and secrete effector cytokines ([@B37]; [@B40]). Major sub-populations of DCs are myeloid DCs, plasmacytoid DC (pDCs) and monocyte-derived DCs ([@B8]; [@B37]). pDC recognize the nucleic acids from *A. fumigatus* via TLR-9 and lead to resistance to *A. fumigatus* infection in mice ([@B41]). Further, monocytes migrate toward the lung to differentiate into either DCs or alveolar macrophages during invasive aspergillosis ([@B18]; [@B34]). Monocytes express different chemokines receptor predominantly CCR2, which help in migration of monocytes from bone marrow toward lung in response to *A. fumigatus* infection ([@B44]). It has been shown that monocytes expressing CCR2 in the lung involved in conidial uptake and killing ([@B22]). Furthermore, alveolar macrophages induce APCs to release IL -1β in pulmonary invasive infection ([@B39]). IL-18 has also been observed in lung during invasive aspergillosis mice model ([@B2]). Recently, it has been observed that *A. fumigatus* pulmonary challenge induces expression of the inflammasome-dependent cytokines IL-1β and IL-18 within the first 12 h, while IL-1α expression continually increases over at least the first 48 h ([@B9]). [@B32] showed in a pulmonary invasive aspergillosis model that mice injected with IL-37 prior to *A*. *fumigatus* infection has significant reduction in IL-β production and recruitment of neutrophils and resulted in diminution in lung inflammation and damage. The anti-inflammatory activity of IL-37 has been observed as an inhibitor of the innate response. Thus, cytokines play a vital role in modulation of immune response and coordinate the innate as well as adaptive responses. APCs secrete cytokines that act on naïve T-cells leading to the differentiation of naïve T-cells. These differentiated T-cells further secrete effector cytokines and regulate the function of T~H~-cells. The profile of cytokine depends on the type of *Aspergillus* antigens, route of infection, immunological status of the host and cytokines milieu present during the interaction ([@B43]; [@B14]). CD4^+^ T-cells can be divided into distinct subtypes according to cytokine profile, and they can differentiate to T~H~1, T~H~2 T~H~17, T~H~9, and T-follicular effector cells ([@B28]; [@B27]). On the basis of the cytokine profile, these T~H~-cells perform distinct functions. However, it is not clear how T-follicular effector cells respond during *Aspergillus* infection ([@B56]).

Cytokines Associated with T~H~1 Type of Response
------------------------------------------------

*Aspergillus fumigatus* challenged intranasally in mice interacts with DCs and alveolar macrophages in the lung. Secretion of T~H~1 associated pro-inflammatory cytokines IL-12, IFN-γ, TNF-α, IL-18 has been observed after the challenge ([@B17]). Among these, IL-12 is the prominent cytokine released from activated monocytes and macrophages in lung that help in shaping T-cell immune response. IL-12 is a heterodimeric cytokine composed of IL-12p35 and IL-12p40 polypeptides that form the bioactive IL-12p70. The heterodimer binds to the IL-12 receptor composed of IL-12Rβ1 and IL-12Rβ2 chains and signals through STAT-4 ([@B47]). IL-12 acts on NK cells to promote IFN-γ secretion and differentiate CD4^+^ T-cells into T~H~1-cells, once CD4^+^ cells differentiates to T~H~1-cells, they increase the secretion of IFN-γ, which suppress T~H~17 and T~H~2 response in the lung ([@B23]; [@B10]). IL-12, hence, is the most important regulator of T~H~1 response during lung infection. IL-12 deficient mice failed to generate a T~H~1 response, leading to increased secretion of IL-4 and IL-10 cytokines, which shifts the immune response toward T~H~2 pathway ([@B12]). In *A. fumigatus* induced neutropenic aspergillosis in mice, NK cells can be the primary source of IFN-γ responsible for activating phagocytic cells and direct antifungal effectors cells against *A. fumigatus* ([@B38]). Further, patients with invasive *Candida* and/or *Aspergillus* infections, recombinant treatment of IFN-γ in combination with antifungal drug partially restored immune function ([@B19]). In intravenous infection of *A. flavus* mice model studies, lung and brain homogenate showed pro-inflammatory cytokines IL-12 and IFN-γ and relative absence of IL-4, IL-23, and IL-17 suggesting a T~H~1 response ([@B3], [@B4]). *A. terreus* induced invasive aspergillosis showed the presence of IL-1β, IL-6, and reduced level of IL-10 in mice model studies. Although there is activation of T~H~17 type of adaptive immune response through IL-1β but the later is suppressed by T~H~1 cytokines particularly IFN-γ ([@B51]; [@B30]). The T~H~1 response is thus also mounted by *A. terreus* and there is a lack of T~H~2 response in contrast to *A. fumigatus* infection where T~H~2 promoting cytokines are observed.

Cytokines Associated with T~H~17 Type Response
----------------------------------------------

*Aspergillus fumigatus* mediated infections in lung induce T~H~17 and T~H~1-cells. These cells play an important role in protection and induction of inflammation ([@B14]). Activation of T~H~17-cell depends on Dectin-1 signaling pathway. Various studies have suggested that dectin-1 deficient mice entirely activate T~H~1-cells. So Dectin-1 signaling not only serves as a positive factor to promote T~H~17 differentiation but rather act to balance T~H~1 versus T~H~17 differentiation. Activation of the APCs by Dectin-1, release the proinflammatory cytokines IL-1β, IL-6, IL-23, and IL-22 which differentiates CD4^+^ T-cells to T~H~17-cells, which further secretes IL-17A and IL-17F cytokines and maintain T~H~17 response ([@B53]). IL-23 is a member of IL-12 family, produced by phagocytic cells, macrophages and activated DCs in lung. IL-23 contains two subunits IL-12p40 and IL-23p19 and it binds to heterodimeric receptors IL-12Rβ1, expressed by activated T-cells ([@B58]). IL-6 is another important cytokine involved in regulation of T~H~17 response. IL-6 is a multifunctional cytokine, promote T~H~17-cells differentiation, inflammation and acute response ([@B2]). During T~H~17 differentiation, human naïve T-cells are exposed to IL-1β, IL-6, and IL-23 ([@B57]; [@B24]). T~H~17 promoting cytokine IL-17 binds to IL-17RA and IL-17RC receptors expressed in lung cells, like fibroblast, epithelial cells and T-cells. After release of IL-17 from T~H~17-cells, it activates the neutrophils migration toward infected area and increases inflammation ([@B55]). In *A. flavus* and *A. terreus*, the role of T~H~17-cells during lung infection is yet to be established.

Cytokines Associated with T~H~2 Type of Response
------------------------------------------------

*Aspergillus fumigatus* is associated with both invasive and allergic form of aspergillosis. In case, if conidia are not cleared, they germinate to produce hyphae, which are responsible for invasion in host tissues that leads to inflammation. In a healthy human T-cells response, *A. fumigatus* not only evoke pro-inflammatory type of immune response via T~H~1 and T~H~17-cells but also anti-inflammatory type of immune response mediated by T~H~2-cells ([@B16]). Immune response initiated by IL-4 and IL-10 inhibits T~H~1 and T~H~17 response and increased secretion of IL-4 and IL-10 inhibits IFN-γ and IL-12 production. T~H~2-cells differentiation depends on IL-4 and IL-10 and after differentiation in to T~H~2 cells, these cells further secretes IL-5 and IL-13 which maintain T~H~2 response. T~H~2 immune response is triggered in acute bronchopulmonary aspergillosis and also in invasive pulmonary infection during some time point of infection. IL-4 and IL-10 deficient mice show lower *A. fumigatus* burden and increased survival rates compared to wild type mouse in invasive pulmonary aspergillosis ([@B11]). It has been shown that ESTs (L3 ribosomal protein, L7A ribosomal protein, Histone -H2A) have high sequence similarity with human counter parts suggesting molecular mimicry between human and pathogen protein ([@B46]). However, role of these genes in eliciting allergic immune response needs investigations. In *A. flavus* mediated infection, lung homogenate showed the absence of T~H~2 response in a limited cytokine profile study ([@B5]). However, T~H~2 type response may get activated in later stages of infection in lung due to rise in IL-4 and IL-10, which suppress the T~H~1 response but consistent expression IFN-γ overcomes T~H~2 response. In addition to T~H~2, the role of T~H~9-cells has been shown during infection with a Virus, bacteria, parasites and fungi. T~H~9 response contributes to allergic inflammation during allergic aspergillosis due to *A. fumigatus* in mice model ([@B28]). T~H~9-cells develop in the presence of IL-1α and TGF-β along with T~H~2-cells. However, role of T~H~9 and T~H~2 response during invasive aspergillosis remains unclear.

Is Their Co-evolution of T-helper Cells During Invasive Aspergillosis?
======================================================================

In a immunocompromised mice model studies, repeated exposure of *A. fumigatus* conidia in hosts lead to co-evolution of T~H~1, T~H~2, and T~H~17 response in infected lung ([@B35]). They have observed the presence of IFN-γ and IL-17 in infected lung of mice along with T~H~2 response. These mixed responses might be occurring at different time points during progression of infection and leads to either protection or infection. T~H~1 and T~H~17 response probably leads to protection where as T~H~2 response further complicates the disease. T~H~2 response help in evasion of *A*. *fumigatus* from immune cells and further increase the IgE level, which leads to high inflammation at the site of infection. Mice model of ABPA demonstrated the T~H~2 cytokine profile consisting of IL-4, IL-10, and IL-5 ([@B31]).

Interplay of Cytokines; T~H~1 or T~H~2 or T~H~17 Type of Response
=================================================================

T~H~-cells response during invasive *Aspergillus* depends on differentiating cytokines. T~H~1 response is activated by differentiating cytokine IL-12 followed by secretion of IFN-γ. Secretion of IFN-γ further stimulates T~H~1 cells, if IFN-γ dominates initially it suppress the other cytokines of T~H~2 and T~H~17, i.e., IL-4 and IL-17 ([@B25]). If IL-4 dominates during initial period of *Aspergillus* infection, it suppresses the protective T~H~1 type immune response by inhibiting differential cytokine IL-12 and IFN-γ ([@B25]). Recognition of *Aspergillus* antigens by Dectin-1 signaling pathway inhibit the production of IFN-γ and IL-12 receptors suppressing T~H~1, which leads to differentiation of T~H~17-cells and production of IL-17. In this way Dectin-1 signal balances the T~H~1 and T~H~17 response through the regulation of their respective cytokines ([@B42]; Figure [1](#F1){ref-type="fig"}). The development of effective CD4^+^ T~H~-cells response not only depends upon cytokines, but also on chemokines and their receptors. Chemokines help in recruitment of leukocytes, i.e., neutrophils, monocytes and NK cells toward lung during *Aspergillus* infection. These cells express chemokine receptors; neutrophils contain CXCR2 chemokine receptor for ligand CXCL1 and CXCL2, monocytes contain CCR2 and CCR6 receptor for CCL2 and CCL20 ligands, where as NK cells contain CCR2 receptor for CCL2 ligand. So these chemokine ligands attract monocytes, neutrophils and NK cells to clear the *Aspergillus* hyphae during lung infection ([@B39]). These chemokines receptors are also present on DCs, regulatory T-cells (Tregs) and T~H~-cells and help in their trafficking ([@B7]). In this way, there is an interdependent relationship between chemokines and cytokines that help in evolution of effector T~H~-cells response. CCL17, a chemokine, help in trafficking of DCs, Tregs and T~H~1-cells toward infected area during invasive aspergillosis in response to CCR4 chemokine receptor present on these cells. Further, CCR6 receptor present on DCs and T~H~17-cells help in migration of these cells in response to chemokine CCL20 ([@B7]; [@B56]).

![**The recognitions, processing and presentation of *Aspergillus* antigens to naïve CD4^+^ T~H~-cells and Production of effector T~H~-cells.** In infected Lung and Kidney, *Aspergillus* antigens (conidia & germinating conidia) are recognized by PRRs, i.e., soluble (C-type lectins) and cell bound receptors; TLR2, TLR4, and TLR9 ([@B36]). They are present on antigen presenting cells (DCs and macrophages). After recognition, antigens recognized by APCs, process and present to naïve CD4^+^ T-cells in secondary lymphoid organs ([@B13]). After interaction of APCs and naïve CD4^+^ T-cells, differential cytokines release (IL-12, IL-6, IL-4, IL-1β) ([@B29]; [@B13]) act upon CD4^+^ T-cells and differentiate them into effector T~H~-cells. IL- 12 give rise to T~H~1, IL-6, IL-1β give rise to T~H~17 and IL-4 give rise to T~H~2 effector T~H~-cells ([@B35]). These effector cells further secrets effector cytokines (IFN-γ, TNF-α, IL-10, IL-5, IL-17, and IL-23) ([@B58]) which maintain effector T~H~-cells response. Figure shows summary of development of effector T~H~-cells response during Lung and Kidney infection of *Aspergillus*. The figure is not to the scale.](fmicb-06-00429-g0001){#F1}

Conclusion
==========

Cytokines are important in the development of CD4^+^ T~H~-cells. Understanding of trafficking of CD4^+^ T~H~-cells and their regulation through differentiating/effector cytokines during invasive aspergillosis will be crucial for the targeted immunotherapy. Overall, cytokines and chemokines may serve as prognostic biomarkers that could be followed to assess the effectiveness of treatment response during invasive aspergillosis. Measurement of selected cytokines in the blood samples of aspergillosis patients may be a promising tool for the monitoring of treatment responses. Also, manipulation of cytokine response e. g, IFN-γ or IFN-γ in combination with antifungal drug, IL-37, may be a future avenue for the development of better therapeutic against invasive aspergillosis.
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